Benjamin F. Edwards & Company, Inc. Lantheus Holdings, Inc. Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 998 shares of LNTH stock, worth $88,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
998Holding current value
$88,951% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LNTH
# of Institutions
540Shares Held
68MCall Options Held
679KPut Options Held
423K-
Black Rock Inc. New York, NY8.6MShares$766 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.42MShares$661 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.59MShares$320 Million0.21% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.96MShares$263 Million1.63% of portfolio
-
State Street Corp Boston, MA2.52MShares$225 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $6.13B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...